| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 48 | 2024 | 4468 | 4.750 |
Why?
|
| Medical Records Systems, Computerized | 28 | 2020 | 1205 | 4.310 |
Why?
|
| Population Surveillance | 40 | 2015 | 2616 | 4.300 |
Why?
|
| Computer Security | 23 | 2022 | 262 | 3.750 |
Why?
|
| Information Dissemination | 15 | 2022 | 1099 | 2.750 |
Why?
|
| Health Insurance Portability and Accountability Act | 6 | 2022 | 99 | 2.720 |
Why?
|
| Confidentiality | 22 | 2022 | 612 | 2.700 |
Why?
|
| Patient Access to Records | 12 | 2016 | 118 | 2.530 |
Why?
|
| Public Health Informatics | 14 | 2012 | 110 | 2.440 |
Why?
|
| Information Storage and Retrieval | 10 | 2019 | 824 | 2.220 |
Why?
|
| Disease Outbreaks | 26 | 2010 | 1772 | 2.220 |
Why?
|
| Software | 20 | 2024 | 4443 | 2.170 |
Why?
|
| Pharyngitis | 7 | 2020 | 215 | 2.030 |
Why?
|
| Bioterrorism | 12 | 2007 | 143 | 1.910 |
Why?
|
| Medical Record Linkage | 9 | 2015 | 284 | 1.910 |
Why?
|
| Health Records, Personal | 8 | 2022 | 124 | 1.890 |
Why?
|
| Streptococcus pyogenes | 7 | 2020 | 289 | 1.880 |
Why?
|
| Internet | 27 | 2016 | 3064 | 1.830 |
Why?
|
| Streptococcal Infections | 8 | 2020 | 638 | 1.790 |
Why?
|
| Medical Informatics | 9 | 2020 | 745 | 1.700 |
Why?
|
| Health Level Seven | 6 | 2021 | 38 | 1.670 |
Why?
|
| Computer Communication Networks | 7 | 2019 | 295 | 1.590 |
Why?
|
| Privacy | 9 | 2022 | 239 | 1.400 |
Why?
|
| Biosurveillance | 2 | 2024 | 17 | 1.370 |
Why?
|
| Insurance Claim Review | 3 | 2020 | 720 | 1.330 |
Why?
|
| Hypertension, Pulmonary | 7 | 2022 | 1537 | 1.330 |
Why?
|
| Lyme Disease | 4 | 2016 | 621 | 1.310 |
Why?
|
| Ecosystem | 2 | 2024 | 474 | 1.280 |
Why?
|
| Artificial Intelligence | 5 | 2024 | 2214 | 1.220 |
Why?
|
| Geographic Information Systems | 5 | 2008 | 281 | 1.200 |
Why?
|
| Insurance Claim Reporting | 4 | 2017 | 163 | 1.200 |
Why?
|
| Influenza, Human | 12 | 2011 | 1479 | 1.180 |
Why?
|
| Emergency Service, Hospital | 28 | 2023 | 7659 | 1.120 |
Why?
|
| Access to Information | 3 | 2022 | 320 | 1.120 |
Why?
|
| Computer Systems | 9 | 2007 | 483 | 1.010 |
Why?
|
| Clinical Trials as Topic | 11 | 2019 | 7913 | 0.970 |
Why?
|
| Inappropriate Prescribing | 2 | 2017 | 202 | 0.930 |
Why?
|
| Humans | 255 | 2024 | 744343 | 0.920 |
Why?
|
| United States | 67 | 2024 | 69872 | 0.900 |
Why?
|
| Genetic Privacy | 3 | 2012 | 60 | 0.890 |
Why?
|
| Hospitals, Pediatric | 14 | 2016 | 1775 | 0.880 |
Why?
|
| Social Support | 4 | 2015 | 2118 | 0.870 |
Why?
|
| Decision Support Techniques | 10 | 2020 | 1956 | 0.870 |
Why?
|
| User-Computer Interface | 10 | 2019 | 1431 | 0.840 |
Why?
|
| Patient Participation | 6 | 2014 | 1457 | 0.820 |
Why?
|
| Current Procedural Terminology | 2 | 2020 | 92 | 0.810 |
Why?
|
| Product Surveillance, Postmarketing | 3 | 2015 | 430 | 0.800 |
Why?
|
| Child | 78 | 2024 | 77709 | 0.800 |
Why?
|
| Medical Records | 8 | 2010 | 1413 | 0.800 |
Why?
|
| United States Federal Trade Commission | 1 | 2021 | 10 | 0.790 |
Why?
|
| Retrospective Studies | 59 | 2024 | 77449 | 0.780 |
Why?
|
| Systems Integration | 11 | 2016 | 440 | 0.770 |
Why?
|
| Social Participation | 2 | 2013 | 173 | 0.750 |
Why?
|
| Cost of Illness | 5 | 2013 | 1859 | 0.750 |
Why?
|
| Data Mining | 4 | 2017 | 537 | 0.720 |
Why?
|
| Algorithms | 16 | 2021 | 13881 | 0.700 |
Why?
|
| Registries | 14 | 2022 | 8089 | 0.700 |
Why?
|
| Biomedical Research | 12 | 2019 | 3309 | 0.690 |
Why?
|
| Models, Statistical | 11 | 2017 | 5102 | 0.670 |
Why?
|
| Pharmacogenetics | 2 | 2021 | 675 | 0.670 |
Why?
|
| Virus Diseases | 3 | 2023 | 711 | 0.660 |
Why?
|
| Primary Health Care | 7 | 2020 | 4558 | 0.660 |
Why?
|
| Vaccines | 3 | 2020 | 822 | 0.650 |
Why?
|
| Delivery of Health Care | 6 | 2024 | 5319 | 0.630 |
Why?
|
| Natural Language Processing | 4 | 2024 | 1041 | 0.630 |
Why?
|
| Point-of-Care Systems | 4 | 2016 | 1177 | 0.620 |
Why?
|
| Organizational Innovation | 2 | 2020 | 559 | 0.610 |
Why?
|
| Hospital Information Systems | 6 | 2011 | 395 | 0.610 |
Why?
|
| Sentinel Surveillance | 4 | 2007 | 281 | 0.600 |
Why?
|
| Databases, Factual | 8 | 2020 | 7729 | 0.600 |
Why?
|
| Public Health | 9 | 2018 | 2603 | 0.600 |
Why?
|
| Medical Informatics Applications | 4 | 2009 | 186 | 0.600 |
Why?
|
| Insurance, Health | 4 | 2020 | 2494 | 0.590 |
Why?
|
| Cluster Analysis | 6 | 2008 | 2715 | 0.580 |
Why?
|
| Health Services Research | 4 | 2011 | 1836 | 0.580 |
Why?
|
| Child, Preschool | 44 | 2021 | 41006 | 0.580 |
Why?
|
| Communication | 7 | 2024 | 3749 | 0.570 |
Why?
|
| Mammography | 3 | 2017 | 2476 | 0.570 |
Why?
|
| Adolescent | 55 | 2022 | 85781 | 0.550 |
Why?
|
| Research Support as Topic | 5 | 2016 | 705 | 0.550 |
Why?
|
| Mass Screening | 4 | 2021 | 5255 | 0.550 |
Why?
|
| Risk Assessment | 14 | 2020 | 23338 | 0.550 |
Why?
|
| Genomics | 6 | 2021 | 5720 | 0.540 |
Why?
|
| Mesalamine | 1 | 2016 | 136 | 0.540 |
Why?
|
| Appendicitis | 5 | 2004 | 645 | 0.540 |
Why?
|
| Respiratory Tract Infections | 4 | 2008 | 961 | 0.540 |
Why?
|
| False Positive Reactions | 2 | 2016 | 981 | 0.540 |
Why?
|
| Anthrax | 3 | 2007 | 88 | 0.530 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2017 | 214 | 0.530 |
Why?
|
| Hospitalization | 10 | 2021 | 10262 | 0.530 |
Why?
|
| Databases as Topic | 1 | 2017 | 475 | 0.530 |
Why?
|
| Tick-Borne Diseases | 1 | 2015 | 34 | 0.530 |
Why?
|
| Early Detection of Cancer | 4 | 2017 | 3086 | 0.520 |
Why?
|
| Biological Factors | 1 | 2016 | 164 | 0.520 |
Why?
|
| Infant | 37 | 2022 | 35136 | 0.510 |
Why?
|
| Health Expenditures | 4 | 2017 | 2348 | 0.500 |
Why?
|
| Pediatrics | 10 | 2019 | 3475 | 0.500 |
Why?
|
| Software Design | 3 | 2012 | 176 | 0.490 |
Why?
|
| Anti-Bacterial Agents | 5 | 2016 | 7181 | 0.490 |
Why?
|
| Language | 1 | 2024 | 1471 | 0.490 |
Why?
|
| Patient Compliance | 3 | 2024 | 2684 | 0.480 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2019 | 783 | 0.480 |
Why?
|
| Computer Simulation | 5 | 2021 | 6196 | 0.480 |
Why?
|
| Epidemics | 1 | 2020 | 523 | 0.470 |
Why?
|
| Female | 85 | 2023 | 380194 | 0.460 |
Why?
|
| Clinical Laboratory Information Systems | 2 | 2012 | 108 | 0.460 |
Why?
|
| Male | 78 | 2021 | 350118 | 0.450 |
Why?
|
| Diabetes Mellitus | 4 | 2013 | 5751 | 0.440 |
Why?
|
| Medical History Taking | 5 | 2009 | 783 | 0.440 |
Why?
|
| Computing Methodologies | 1 | 2012 | 17 | 0.430 |
Why?
|
| DNA Fingerprinting | 1 | 2012 | 112 | 0.430 |
Why?
|
| Databases, Genetic | 5 | 2021 | 1783 | 0.430 |
Why?
|
| Massachusetts | 17 | 2011 | 8663 | 0.430 |
Why?
|
| Information Systems | 2 | 2012 | 410 | 0.420 |
Why?
|
| Insulin Infusion Systems | 1 | 2013 | 212 | 0.420 |
Why?
|
| Disclosure | 2 | 2012 | 736 | 0.420 |
Why?
|
| Drug Interactions | 1 | 2017 | 1460 | 0.420 |
Why?
|
| Online Systems | 1 | 2013 | 184 | 0.420 |
Why?
|
| Informatics | 1 | 2012 | 72 | 0.410 |
Why?
|
| Epilepsy | 3 | 2022 | 3310 | 0.410 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2012 | 3923 | 0.400 |
Why?
|
| Patient Selection | 4 | 2017 | 4215 | 0.400 |
Why?
|
| Bayes Theorem | 3 | 2020 | 2309 | 0.400 |
Why?
|
| Databases, Nucleic Acid | 1 | 2012 | 211 | 0.400 |
Why?
|
| Boston | 15 | 2016 | 9313 | 0.400 |
Why?
|
| Empirical Research | 1 | 2012 | 120 | 0.400 |
Why?
|
| Fever | 4 | 2012 | 1616 | 0.400 |
Why?
|
| Parents | 10 | 2016 | 3407 | 0.390 |
Why?
|
| Models, Organizational | 1 | 2015 | 574 | 0.390 |
Why?
|
| Rhabdomyolysis | 1 | 2012 | 150 | 0.380 |
Why?
|
| Developed Countries | 1 | 2013 | 437 | 0.380 |
Why?
|
| Adult | 45 | 2023 | 214055 | 0.380 |
Why?
|
| Cooperative Behavior | 2 | 2017 | 1504 | 0.380 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2013 | 434 | 0.380 |
Why?
|
| Security Measures | 2 | 2008 | 77 | 0.380 |
Why?
|
| Sensitivity and Specificity | 18 | 2021 | 14722 | 0.370 |
Why?
|
| Hospital Communication Systems | 2 | 2017 | 51 | 0.370 |
Why?
|
| Hypoglycemic Agents | 3 | 2019 | 2872 | 0.370 |
Why?
|
| Infant, Newborn | 27 | 2022 | 25625 | 0.370 |
Why?
|
| Drugs, Investigational | 1 | 2012 | 214 | 0.360 |
Why?
|
| Epilepsy, Rolandic | 2 | 2021 | 50 | 0.360 |
Why?
|
| Chronic Disease | 4 | 2013 | 9146 | 0.360 |
Why?
|
| Maps as Topic | 2 | 2006 | 17 | 0.360 |
Why?
|
| Purpura | 2 | 2003 | 122 | 0.360 |
Why?
|
| Secondary Prevention | 1 | 2016 | 1530 | 0.360 |
Why?
|
| Education, Medical | 1 | 2022 | 1721 | 0.350 |
Why?
|
| Comparative Effectiveness Research | 2 | 2012 | 681 | 0.350 |
Why?
|
| Respiratory Sounds | 1 | 2014 | 696 | 0.350 |
Why?
|
| Publication Bias | 1 | 2010 | 162 | 0.350 |
Why?
|
| Models, Theoretical | 4 | 2012 | 3589 | 0.350 |
Why?
|
| Ambulatory Care | 3 | 2017 | 2708 | 0.350 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2014 | 428 | 0.350 |
Why?
|
| Whooping Cough | 1 | 2010 | 82 | 0.340 |
Why?
|
| Information Services | 3 | 2008 | 244 | 0.340 |
Why?
|
| Benzodiazepines | 1 | 2015 | 1101 | 0.340 |
Why?
|
| Drug Utilization | 1 | 2015 | 1183 | 0.340 |
Why?
|
| Epidemiologic Measurements | 3 | 2005 | 23 | 0.340 |
Why?
|
| Middle Aged | 34 | 2021 | 213383 | 0.330 |
Why?
|
| Drug Evaluation | 1 | 2010 | 647 | 0.330 |
Why?
|
| Pharmacoepidemiology | 1 | 2012 | 323 | 0.330 |
Why?
|
| Medicare Part C | 1 | 2013 | 296 | 0.330 |
Why?
|
| Accidental Falls | 1 | 2017 | 1062 | 0.330 |
Why?
|
| Students, Medical | 1 | 2022 | 1862 | 0.330 |
Why?
|
| Drug Monitoring | 2 | 2012 | 956 | 0.330 |
Why?
|
| Practice Guidelines as Topic | 7 | 2016 | 7279 | 0.330 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2012 | 469 | 0.330 |
Why?
|
| Adolescent Health Services | 1 | 2011 | 215 | 0.320 |
Why?
|
| American Recovery and Reinvestment Act | 2 | 2020 | 71 | 0.320 |
Why?
|
| Drug Approval | 2 | 2014 | 742 | 0.320 |
Why?
|
| Hospital Costs | 4 | 2017 | 985 | 0.320 |
Why?
|
| Data Collection | 6 | 2021 | 3341 | 0.320 |
Why?
|
| Genome, Human | 2 | 2019 | 4420 | 0.320 |
Why?
|
| Reimbursement, Incentive | 1 | 2013 | 540 | 0.320 |
Why?
|
| Research Design | 6 | 2017 | 5987 | 0.320 |
Why?
|
| Social Adjustment | 1 | 2011 | 631 | 0.320 |
Why?
|
| Publishing | 2 | 2021 | 833 | 0.310 |
Why?
|
| Domestic Violence | 1 | 2009 | 176 | 0.310 |
Why?
|
| Polypharmacy | 1 | 2010 | 294 | 0.310 |
Why?
|
| Cohort Studies | 20 | 2023 | 40561 | 0.310 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 3255 | 0.310 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2009 | 329 | 0.310 |
Why?
|
| General Practitioners | 2 | 2019 | 103 | 0.300 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2009 | 139 | 0.300 |
Why?
|
| Patient-Centered Care | 2 | 2016 | 1439 | 0.300 |
Why?
|
| Young Adult | 20 | 2021 | 56430 | 0.300 |
Why?
|
| Suicide | 3 | 2023 | 1477 | 0.290 |
Why?
|
| Autoimmune Diseases | 2 | 2021 | 2133 | 0.290 |
Why?
|
| Prostate-Specific Antigen | 1 | 2017 | 2494 | 0.290 |
Why?
|
| West Nile Fever | 1 | 2007 | 81 | 0.290 |
Why?
|
| Commerce | 1 | 2012 | 592 | 0.290 |
Why?
|
| Meningitis, Aseptic | 1 | 2007 | 58 | 0.290 |
Why?
|
| Community Networks | 1 | 2008 | 203 | 0.290 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2012 | 738 | 0.290 |
Why?
|
| Facial Paralysis | 1 | 2011 | 338 | 0.280 |
Why?
|
| Drug Prescriptions | 2 | 2015 | 1637 | 0.280 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.280 |
Why?
|
| Age Factors | 9 | 2017 | 18370 | 0.280 |
Why?
|
| Patient Care Team | 2 | 2015 | 2531 | 0.280 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2008 | 157 | 0.280 |
Why?
|
| Brain Waves | 2 | 2021 | 401 | 0.280 |
Why?
|
| Physicians | 2 | 2024 | 4567 | 0.280 |
Why?
|
| Syndrome | 4 | 2006 | 3251 | 0.280 |
Why?
|
| Epidemiologic Methods | 2 | 2008 | 1364 | 0.270 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2017 | 1462 | 0.270 |
Why?
|
| Safety | 1 | 2011 | 1186 | 0.270 |
Why?
|
| Aircraft | 1 | 2006 | 123 | 0.270 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 1148 | 0.270 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2017 | 1458 | 0.260 |
Why?
|
| Hypoglycemia | 1 | 2013 | 861 | 0.260 |
Why?
|
| Anticonvulsants | 1 | 2015 | 1916 | 0.260 |
Why?
|
| Government Regulation | 3 | 2017 | 522 | 0.260 |
Why?
|
| Regional Medical Programs | 1 | 2006 | 71 | 0.260 |
Why?
|
| Mandatory Reporting | 1 | 2006 | 121 | 0.260 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2007 | 371 | 0.260 |
Why?
|
| Foreign Bodies | 2 | 2000 | 399 | 0.260 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3133 | 0.260 |
Why?
|
| Patient Care | 2 | 2024 | 640 | 0.260 |
Why?
|
| Disease | 2 | 2008 | 680 | 0.260 |
Why?
|
| Time Factors | 13 | 2021 | 40075 | 0.260 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3240 | 0.260 |
Why?
|
| Lactones | 1 | 2007 | 329 | 0.250 |
Why?
|
| Sulfones | 1 | 2007 | 437 | 0.250 |
Why?
|
| Drug Industry | 4 | 2016 | 746 | 0.250 |
Why?
|
| Developing Countries | 2 | 2015 | 2815 | 0.250 |
Why?
|
| Meningitis, Bacterial | 1 | 2007 | 218 | 0.250 |
Why?
|
| Attitude of Health Personnel | 3 | 2018 | 3843 | 0.250 |
Why?
|
| Baseball | 1 | 2005 | 90 | 0.250 |
Why?
|
| Health Care Costs | 2 | 2017 | 3209 | 0.240 |
Why?
|
| Breast Neoplasms | 3 | 2017 | 20822 | 0.240 |
Why?
|
| Postnatal Care | 4 | 2004 | 236 | 0.240 |
Why?
|
| Spinal Puncture | 1 | 2006 | 281 | 0.240 |
Why?
|
| Mass Vaccination | 1 | 2005 | 105 | 0.240 |
Why?
|
| Research Subjects | 2 | 2017 | 239 | 0.240 |
Why?
|
| Odds Ratio | 6 | 2021 | 9849 | 0.230 |
Why?
|
| Patient Transfer | 1 | 2011 | 761 | 0.230 |
Why?
|
| Health Services | 2 | 2000 | 758 | 0.230 |
Why?
|
| Esophagus | 2 | 2000 | 1019 | 0.230 |
Why?
|
| Crohn Disease | 1 | 2016 | 2303 | 0.230 |
Why?
|
| Multivariate Analysis | 8 | 2016 | 12245 | 0.230 |
Why?
|
| Regression Analysis | 7 | 2020 | 6459 | 0.230 |
Why?
|
| Patient Readmission | 2 | 2017 | 3114 | 0.230 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 1049 | 0.230 |
Why?
|
| Thermometers | 1 | 2023 | 46 | 0.230 |
Why?
|
| APACHE | 1 | 2024 | 277 | 0.230 |
Why?
|
| Interdisciplinary Communication | 2 | 2008 | 950 | 0.230 |
Why?
|
| International Classification of Diseases | 3 | 2009 | 867 | 0.220 |
Why?
|
| Decision Support Systems, Clinical | 3 | 2016 | 1164 | 0.220 |
Why?
|
| Incidence | 9 | 2015 | 20947 | 0.220 |
Why?
|
| Immunization | 1 | 2007 | 1256 | 0.220 |
Why?
|
| Partial Thromboplastin Time | 1 | 2003 | 206 | 0.220 |
Why?
|
| Public Health Administration | 2 | 2005 | 240 | 0.210 |
Why?
|
| Influenza Vaccines | 2 | 2011 | 738 | 0.210 |
Why?
|
| Attitude to Computers | 2 | 2000 | 202 | 0.210 |
Why?
|
| Patients | 2 | 2000 | 900 | 0.210 |
Why?
|
| Logistic Models | 8 | 2012 | 13408 | 0.210 |
Why?
|
| Medication Adherence | 1 | 2013 | 2063 | 0.210 |
Why?
|
| Aged | 20 | 2020 | 163280 | 0.210 |
Why?
|
| Opsoclonus-Myoclonus Syndrome | 1 | 2021 | 8 | 0.210 |
Why?
|
| Ireland | 1 | 2022 | 161 | 0.210 |
Why?
|
| Ciprofloxacin | 1 | 2004 | 315 | 0.210 |
Why?
|
| Forecasting | 3 | 2020 | 2951 | 0.200 |
Why?
|
| Quality Indicators, Health Care | 1 | 2012 | 1831 | 0.200 |
Why?
|
| Reproducibility of Results | 11 | 2021 | 19905 | 0.200 |
Why?
|
| Phenotype | 6 | 2021 | 16365 | 0.200 |
Why?
|
| Length of Stay | 5 | 2004 | 6309 | 0.200 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2014 | 3658 | 0.200 |
Why?
|
| Dehydration | 1 | 2003 | 234 | 0.200 |
Why?
|
| Health Policy | 3 | 2009 | 2661 | 0.190 |
Why?
|
| Geography | 4 | 2008 | 669 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2017 | 9959 | 0.190 |
Why?
|
| Entropy | 1 | 2021 | 209 | 0.190 |
Why?
|
| Telemedicine | 2 | 2016 | 2872 | 0.190 |
Why?
|
| Seasons | 4 | 2007 | 1493 | 0.190 |
Why?
|
| Pandemics | 6 | 2023 | 8388 | 0.190 |
Why?
|
| Travel | 1 | 2006 | 788 | 0.180 |
Why?
|
| Consumer Product Safety | 1 | 2021 | 122 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2021 | 11725 | 0.180 |
Why?
|
| Glutamine | 1 | 2023 | 578 | 0.180 |
Why?
|
| Prevalence | 7 | 2021 | 15226 | 0.180 |
Why?
|
| Cross-Sectional Studies | 8 | 2018 | 25043 | 0.180 |
Why?
|
| Papillomavirus Vaccines | 2 | 2017 | 491 | 0.180 |
Why?
|
| Physician-Patient Relations | 4 | 2012 | 3229 | 0.180 |
Why?
|
| Interprofessional Relations | 2 | 2017 | 1011 | 0.180 |
Why?
|
| Humidity | 1 | 2020 | 197 | 0.180 |
Why?
|
| Predictive Value of Tests | 8 | 2017 | 15076 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 3022 | 0.170 |
Why?
|
| Office Visits | 2 | 2014 | 598 | 0.170 |
Why?
|
| Ethics Committees, Research | 2 | 2019 | 194 | 0.170 |
Why?
|
| Empathy | 1 | 2024 | 474 | 0.170 |
Why?
|
| Infection Control | 1 | 2006 | 966 | 0.170 |
Why?
|
| Urine | 1 | 2000 | 370 | 0.170 |
Why?
|
| Molecular Sequence Annotation | 2 | 2019 | 528 | 0.170 |
Why?
|
| Genetic Research | 2 | 2012 | 174 | 0.160 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2004 | 639 | 0.160 |
Why?
|
| Benchmarking | 1 | 2005 | 1042 | 0.160 |
Why?
|
| Quality of Health Care | 2 | 2011 | 4371 | 0.160 |
Why?
|
| Respiratory Tract Diseases | 1 | 2004 | 722 | 0.160 |
Why?
|
| Drug Labeling | 1 | 2021 | 233 | 0.160 |
Why?
|
| Fragile X Syndrome | 1 | 2020 | 115 | 0.160 |
Why?
|
| Seizures | 2 | 2022 | 2859 | 0.160 |
Why?
|
| Personal Autonomy | 2 | 2012 | 298 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 3336 | 0.160 |
Why?
|
| Computational Biology | 2 | 2021 | 3521 | 0.160 |
Why?
|
| Blood | 1 | 2000 | 598 | 0.160 |
Why?
|
| Education | 1 | 2021 | 543 | 0.160 |
Why?
|
| Nervous System Diseases | 3 | 2016 | 1622 | 0.150 |
Why?
|
| Sulfonamides | 1 | 2007 | 1938 | 0.150 |
Why?
|
| Peer Review | 1 | 2020 | 209 | 0.150 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 3507 | 0.150 |
Why?
|
| Cerebrospinal Fluid | 1 | 2000 | 534 | 0.150 |
Why?
|
| Age Distribution | 5 | 2011 | 2902 | 0.150 |
Why?
|
| Documentation | 1 | 2024 | 871 | 0.150 |
Why?
|
| Mass Media | 3 | 2009 | 305 | 0.150 |
Why?
|
| Infant Welfare | 1 | 1997 | 81 | 0.150 |
Why?
|
| Meningococcal Infections | 1 | 1997 | 77 | 0.150 |
Why?
|
| Neonatal Screening | 1 | 2002 | 591 | 0.150 |
Why?
|
| Neisseria meningitidis | 1 | 1997 | 109 | 0.150 |
Why?
|
| Electroencephalography | 3 | 2022 | 6150 | 0.150 |
Why?
|
| Sleep Stages | 1 | 2021 | 686 | 0.150 |
Why?
|
| United States Food and Drug Administration | 3 | 2014 | 1584 | 0.150 |
Why?
|
| Hypolipidemic Agents | 2 | 2012 | 604 | 0.150 |
Why?
|
| Pyrazoles | 1 | 2007 | 1972 | 0.150 |
Why?
|
| Maternal Welfare | 1 | 1997 | 115 | 0.150 |
Why?
|
| Classification | 1 | 2017 | 129 | 0.150 |
Why?
|
| History, 21st Century | 2 | 2020 | 1534 | 0.150 |
Why?
|
| Quality Improvement | 1 | 2012 | 3749 | 0.140 |
Why?
|
| Selection Bias | 1 | 2019 | 371 | 0.140 |
Why?
|
| INDEL Mutation | 1 | 2018 | 279 | 0.140 |
Why?
|
| Prescription Drugs | 2 | 2017 | 595 | 0.140 |
Why?
|
| Models, Biological | 4 | 2011 | 9583 | 0.140 |
Why?
|
| Normal Distribution | 2 | 2008 | 280 | 0.140 |
Why?
|
| Anti-Infective Agents | 1 | 2004 | 972 | 0.140 |
Why?
|
| American Cancer Society | 1 | 2016 | 61 | 0.140 |
Why?
|
| Financing, Government | 2 | 2010 | 468 | 0.140 |
Why?
|
| Neuraminidase | 1 | 2016 | 210 | 0.140 |
Why?
|
| Educational Status | 4 | 2010 | 2540 | 0.140 |
Why?
|
| Guideline Adherence | 1 | 2006 | 2266 | 0.140 |
Why?
|
| Bacterial Infections | 2 | 2003 | 1401 | 0.140 |
Why?
|
| Asthma | 2 | 2014 | 6011 | 0.130 |
Why?
|
| Health Promotion | 1 | 2008 | 2205 | 0.130 |
Why?
|
| ROC Curve | 3 | 2021 | 3527 | 0.130 |
Why?
|
| Communicable Diseases | 3 | 2009 | 880 | 0.130 |
Why?
|
| Gastroesophageal Reflux | 1 | 2022 | 782 | 0.130 |
Why?
|
| Programming Languages | 1 | 2015 | 133 | 0.130 |
Why?
|
| Semantics | 1 | 2019 | 584 | 0.130 |
Why?
|
| Bacteremia | 2 | 2003 | 962 | 0.130 |
Why?
|
| Fourier Analysis | 2 | 2006 | 447 | 0.130 |
Why?
|
| Health Resources | 2 | 2013 | 911 | 0.130 |
Why?
|
| Emergency Medical Services | 2 | 2005 | 1917 | 0.130 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2016 | 204 | 0.120 |
Why?
|
| Depression, Postpartum | 1 | 1999 | 340 | 0.120 |
Why?
|
| Ultrasonography | 4 | 2004 | 5985 | 0.120 |
Why?
|
| Cost Savings | 2 | 2016 | 926 | 0.120 |
Why?
|
| Copyright | 1 | 2014 | 14 | 0.120 |
Why?
|
| Risk Factors | 10 | 2017 | 72290 | 0.120 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15540 | 0.120 |
Why?
|
| Research Personnel | 1 | 2019 | 573 | 0.120 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2016 | 230 | 0.120 |
Why?
|
| Biological Specimen Banks | 1 | 2019 | 711 | 0.120 |
Why?
|
| Down Syndrome | 1 | 2022 | 880 | 0.120 |
Why?
|
| Prostatic Neoplasms | 2 | 2017 | 11124 | 0.120 |
Why?
|
| Review Literature as Topic | 1 | 2016 | 336 | 0.120 |
Why?
|
| Embryonic Development | 1 | 2019 | 711 | 0.120 |
Why?
|
| Ileum | 1 | 2016 | 565 | 0.120 |
Why?
|
| Data Interpretation, Statistical | 2 | 2009 | 2716 | 0.120 |
Why?
|
| Pharmacies | 1 | 2015 | 150 | 0.120 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 264 | 0.120 |
Why?
|
| PubMed | 1 | 2014 | 123 | 0.120 |
Why?
|
| Life Tables | 1 | 2013 | 370 | 0.120 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 687 | 0.110 |
Why?
|
| Child Health Services | 1 | 1999 | 667 | 0.110 |
Why?
|
| Neuropsychiatry | 1 | 2013 | 55 | 0.110 |
Why?
|
| Homozygote | 1 | 2018 | 1785 | 0.110 |
Why?
|
| Authorship | 1 | 2016 | 271 | 0.110 |
Why?
|
| Blood Pressure Determination | 1 | 2017 | 634 | 0.110 |
Why?
|
| Heart Failure | 1 | 2017 | 10900 | 0.110 |
Why?
|
| Organizations | 1 | 2014 | 170 | 0.110 |
Why?
|
| Siblings | 1 | 2017 | 854 | 0.110 |
Why?
|
| Hepatitis C, Chronic | 1 | 2021 | 1031 | 0.110 |
Why?
|
| Medical Staff, Hospital | 1 | 2017 | 603 | 0.110 |
Why?
|
| Vaccination | 2 | 2020 | 3278 | 0.110 |
Why?
|
| Equipment Safety | 1 | 2013 | 264 | 0.110 |
Why?
|
| Computer-Assisted Instruction | 2 | 2008 | 365 | 0.110 |
Why?
|
| Patient Discharge | 4 | 2003 | 3313 | 0.110 |
Why?
|
| Pneumococcal Infections | 1 | 1997 | 497 | 0.110 |
Why?
|
| Early Diagnosis | 2 | 2009 | 1184 | 0.110 |
Why?
|
| Poisoning | 1 | 1994 | 249 | 0.110 |
Why?
|
| Back Pain | 1 | 2016 | 545 | 0.110 |
Why?
|
| Joint Diseases | 1 | 2016 | 480 | 0.110 |
Why?
|
| Prospective Studies | 14 | 2019 | 53288 | 0.100 |
Why?
|
| Marketing | 1 | 2014 | 212 | 0.100 |
Why?
|
| Decision Trees | 2 | 2007 | 506 | 0.100 |
Why?
|
| Gestational Age | 1 | 2021 | 3493 | 0.100 |
Why?
|
| Comorbidity | 3 | 2020 | 10388 | 0.100 |
Why?
|
| Rare Diseases | 1 | 2016 | 553 | 0.100 |
Why?
|
| Sickness Impact Profile | 1 | 2013 | 302 | 0.100 |
Why?
|
| Serum Amyloid A Protein | 1 | 1991 | 121 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3597 | 0.100 |
Why?
|
| Conflict of Interest | 1 | 2016 | 544 | 0.100 |
Why?
|
| Choice Behavior | 1 | 2017 | 803 | 0.100 |
Why?
|
| Colectomy | 1 | 2016 | 683 | 0.100 |
Why?
|
| Jaundice, Neonatal | 2 | 2004 | 71 | 0.100 |
Why?
|
| Postoperative Period | 1 | 2016 | 1842 | 0.100 |
Why?
|
| Heterozygote | 1 | 2018 | 2804 | 0.100 |
Why?
|
| Equipment Failure | 1 | 2013 | 578 | 0.100 |
Why?
|
| Public Opinion | 1 | 2015 | 477 | 0.100 |
Why?
|
| Hepatitis C | 1 | 2021 | 1591 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2004 | 20129 | 0.100 |
Why?
|
| Disaster Planning | 3 | 2005 | 549 | 0.100 |
Why?
|
| Eligibility Determination | 1 | 2014 | 403 | 0.100 |
Why?
|
| Sample Size | 1 | 2014 | 845 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2021 | 13989 | 0.090 |
Why?
|
| National Library of Medicine (U.S.) | 1 | 2010 | 35 | 0.090 |
Why?
|
| Drug Therapy | 1 | 2013 | 497 | 0.090 |
Why?
|
| Insulin | 2 | 2017 | 6580 | 0.090 |
Why?
|
| Income | 3 | 2015 | 1913 | 0.090 |
Why?
|
| Metformin | 1 | 2017 | 835 | 0.090 |
Why?
|
| Tracheotomy | 1 | 2011 | 166 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 1708 | 0.090 |
Why?
|
| Ethics, Research | 1 | 2012 | 191 | 0.090 |
Why?
|
| Health Maintenance Organizations | 2 | 2003 | 642 | 0.090 |
Why?
|
| Acute Disease | 2 | 2012 | 7149 | 0.090 |
Why?
|
| Hospitals | 2 | 2017 | 3952 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6365 | 0.090 |
Why?
|
| Sweden | 1 | 2012 | 1345 | 0.090 |
Why?
|
| Fatigue | 1 | 2016 | 1531 | 0.090 |
Why?
|
| Telephone | 2 | 2003 | 617 | 0.090 |
Why?
|
| Equipment and Supplies | 1 | 2012 | 281 | 0.080 |
Why?
|
| Patient Identification Systems | 2 | 2007 | 79 | 0.080 |
Why?
|
| Environment | 2 | 2020 | 1124 | 0.080 |
Why?
|
| Technology, Pharmaceutical | 1 | 2009 | 84 | 0.080 |
Why?
|
| Financing, Organized | 1 | 2010 | 202 | 0.080 |
Why?
|
| Mothers | 1 | 1999 | 2165 | 0.080 |
Why?
|
| Editorial Policies | 2 | 2010 | 451 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2183 | 0.080 |
Why?
|
| Altruism | 1 | 2010 | 204 | 0.080 |
Why?
|
| Radio | 1 | 2007 | 9 | 0.080 |
Why?
|
| Colon | 1 | 2016 | 1772 | 0.080 |
Why?
|
| Consumer Health Information | 1 | 2011 | 211 | 0.080 |
Why?
|
| New York | 2 | 2008 | 886 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2021 | 63114 | 0.080 |
Why?
|
| Utilization Review | 1 | 2009 | 392 | 0.080 |
Why?
|
| Genetic Counseling | 1 | 2012 | 600 | 0.080 |
Why?
|
| Follow-Up Studies | 5 | 2017 | 39050 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2012 | 1654 | 0.080 |
Why?
|
| Confidence Intervals | 2 | 2011 | 2971 | 0.080 |
Why?
|
| Electronics, Medical | 1 | 2007 | 71 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2016 | 2740 | 0.080 |
Why?
|
| Medical Audit | 1 | 2009 | 467 | 0.080 |
Why?
|
| New England | 1 | 2010 | 1022 | 0.070 |
Why?
|
| Family Characteristics | 1 | 2012 | 1000 | 0.070 |
Why?
|
| Occupational Health Services | 1 | 2008 | 154 | 0.070 |
Why?
|
| Poisson Distribution | 1 | 2008 | 513 | 0.070 |
Why?
|
| Health Status Indicators | 1 | 2012 | 969 | 0.070 |
Why?
|
| Russia | 1 | 2007 | 408 | 0.070 |
Why?
|
| Health Personnel | 1 | 2020 | 3218 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2016 | 1886 | 0.070 |
Why?
|
| Postal Service | 1 | 2006 | 96 | 0.070 |
Why?
|
| Linear Models | 3 | 2013 | 5952 | 0.070 |
Why?
|
| Virus Cultivation | 1 | 2006 | 92 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 2148 | 0.070 |
Why?
|
| Physical Examination | 2 | 2003 | 1237 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 11727 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2014 | 941 | 0.070 |
Why?
|
| Medical Order Entry Systems | 1 | 2011 | 545 | 0.070 |
Why?
|
| Database Management Systems | 1 | 2007 | 270 | 0.070 |
Why?
|
| Attitude to Health | 1 | 2015 | 2052 | 0.070 |
Why?
|
| Organizational Policy | 1 | 2008 | 429 | 0.070 |
Why?
|
| State Government | 1 | 2008 | 372 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 4584 | 0.070 |
Why?
|
| Outpatients | 2 | 2010 | 1486 | 0.070 |
Why?
|
| Patient Education as Topic | 2 | 2008 | 2278 | 0.070 |
Why?
|
| Censuses | 1 | 2006 | 200 | 0.070 |
Why?
|
| Time | 1 | 2007 | 542 | 0.070 |
Why?
|
| Focus Groups | 1 | 2010 | 1321 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 3798 | 0.060 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2006 | 113 | 0.060 |
Why?
|
| Feedback | 1 | 2009 | 795 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2007 | 12959 | 0.060 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 1587 | 0.060 |
Why?
|
| Emergencies | 2 | 2003 | 1170 | 0.060 |
Why?
|
| Markov Chains | 1 | 2008 | 969 | 0.060 |
Why?
|
| Leukocytosis | 1 | 2006 | 247 | 0.060 |
Why?
|
| Awareness | 1 | 2009 | 640 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2017 | 3444 | 0.060 |
Why?
|
| Hospital Charges | 2 | 2013 | 362 | 0.060 |
Why?
|
| Recurrence | 1 | 2016 | 8340 | 0.060 |
Why?
|
| Forms and Records Control | 2 | 2005 | 160 | 0.060 |
Why?
|
| Perception | 1 | 2011 | 1198 | 0.060 |
Why?
|
| National Health Programs | 1 | 2007 | 445 | 0.060 |
Why?
|
| Pharmaceutical Preparations | 1 | 2012 | 1071 | 0.060 |
Why?
|
| Prothrombin Time | 1 | 2003 | 119 | 0.060 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2003 | 43 | 0.060 |
Why?
|
| Appendix | 1 | 2004 | 110 | 0.050 |
Why?
|
| Mental Disorders | 2 | 2020 | 6600 | 0.050 |
Why?
|
| Immunization Programs | 1 | 2005 | 260 | 0.050 |
Why?
|
| Television | 1 | 2005 | 409 | 0.050 |
Why?
|
| Learning | 1 | 2012 | 1713 | 0.050 |
Why?
|
| Trauma Severity Indices | 1 | 2004 | 481 | 0.050 |
Why?
|
| Intellectual Property | 1 | 2022 | 31 | 0.050 |
Why?
|
| Bacteriological Techniques | 1 | 2003 | 277 | 0.050 |
Why?
|
| Mandatory Testing | 1 | 2002 | 23 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 1681 | 0.050 |
Why?
|
| Viruses | 1 | 2006 | 374 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 2046 | 0.050 |
Why?
|
| Third-Party Consent | 1 | 2002 | 64 | 0.050 |
Why?
|
| Workplace | 1 | 2008 | 836 | 0.050 |
Why?
|
| Tears | 1 | 2003 | 256 | 0.050 |
Why?
|
| Electronic Mail | 1 | 2003 | 213 | 0.050 |
Why?
|
| Endophenotypes | 1 | 2023 | 250 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2019 | 6544 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 3508 | 0.050 |
Why?
|
| Sex Factors | 2 | 2017 | 10397 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2017 | 8554 | 0.050 |
Why?
|
| Infant Care | 1 | 2002 | 183 | 0.050 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2022 | 264 | 0.050 |
Why?
|
| Guidelines as Topic | 2 | 2017 | 1405 | 0.050 |
Why?
|
| Emergency Medicine | 2 | 2002 | 1207 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2009 | 1058 | 0.050 |
Why?
|
| Self Report | 1 | 2012 | 3558 | 0.050 |
Why?
|
| Risk | 2 | 2011 | 9687 | 0.050 |
Why?
|
| Intestinal Perforation | 1 | 2002 | 253 | 0.050 |
Why?
|
| Hospitals, Urban | 1 | 2003 | 499 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2012 | 3474 | 0.050 |
Why?
|
| Informed Consent | 1 | 2007 | 995 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 57776 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 1998 | 5137 | 0.050 |
Why?
|
| Calibration | 1 | 2003 | 816 | 0.050 |
Why?
|
| Demography | 1 | 2005 | 1656 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 3610 | 0.050 |
Why?
|
| Communication Barriers | 1 | 2003 | 398 | 0.050 |
Why?
|
| Quality Control | 1 | 2003 | 841 | 0.040 |
Why?
|
| Program Development | 1 | 2006 | 1316 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2003 | 894 | 0.040 |
Why?
|
| Urinary Tract Infections | 2 | 2009 | 788 | 0.040 |
Why?
|
| Quality of Life | 3 | 2021 | 12804 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 1991 | 3778 | 0.040 |
Why?
|
| Disease Progression | 1 | 2016 | 13284 | 0.040 |
Why?
|
| Appendectomy | 1 | 2002 | 401 | 0.040 |
Why?
|
| Antipsychotic Agents | 1 | 2013 | 3057 | 0.040 |
Why?
|
| Public Health Practice | 1 | 2002 | 218 | 0.040 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2020 | 117 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2010 | 1432 | 0.040 |
Why?
|
| Georgia | 1 | 2019 | 186 | 0.040 |
Why?
|
| Remission, Spontaneous | 1 | 1999 | 382 | 0.040 |
Why?
|
| Dilatation | 1 | 2000 | 291 | 0.040 |
Why?
|
| Population Dynamics | 1 | 2020 | 302 | 0.040 |
Why?
|
| Substance-Related Disorders | 2 | 2017 | 4258 | 0.040 |
Why?
|
| Education, Medical, Continuing | 1 | 2004 | 840 | 0.040 |
Why?
|
| Patient Satisfaction | 2 | 2003 | 3396 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2000 | 390 | 0.040 |
Why?
|
| Breast Feeding | 2 | 2004 | 1338 | 0.040 |
Why?
|
| Peer Review, Research | 1 | 2021 | 329 | 0.040 |
Why?
|
| Hyperbilirubinemia | 1 | 1998 | 77 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2022 | 977 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2425 | 0.040 |
Why?
|
| Ankle Injuries | 1 | 2001 | 331 | 0.040 |
Why?
|
| Patient Care Management | 1 | 2000 | 306 | 0.040 |
Why?
|
| Liability, Legal | 1 | 1998 | 213 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2020 | 772 | 0.040 |
Why?
|
| Hypertension | 1 | 2017 | 8480 | 0.040 |
Why?
|
| Qualitative Research | 2 | 2019 | 2682 | 0.040 |
Why?
|
| Mental Recall | 1 | 2003 | 1205 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2004 | 1257 | 0.040 |
Why?
|
| Research | 2 | 2002 | 1999 | 0.030 |
Why?
|
| Health Surveys | 1 | 2006 | 4037 | 0.030 |
Why?
|
| Health Behavior | 1 | 2008 | 2636 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2009 | 8324 | 0.030 |
Why?
|
| North America | 1 | 2019 | 1249 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2003 | 1179 | 0.030 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2016 | 314 | 0.030 |
Why?
|
| Patient Advocacy | 1 | 1997 | 353 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2002 | 857 | 0.030 |
Why?
|
| Stomach | 1 | 1999 | 697 | 0.030 |
Why?
|
| Opioid-Related Disorders | 1 | 2009 | 2065 | 0.030 |
Why?
|
| Managed Care Programs | 1 | 2000 | 950 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 17446 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2019 | 2327 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2017 | 7785 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2020 | 1354 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2000 | 1086 | 0.030 |
Why?
|
| Pain | 1 | 2009 | 4986 | 0.030 |
Why?
|
| Action Potentials | 1 | 2021 | 1806 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2009 | 3674 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2021 | 1912 | 0.030 |
Why?
|
| Health Care Surveys | 2 | 2011 | 2453 | 0.030 |
Why?
|
| Decision Making | 1 | 2007 | 3887 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12261 | 0.030 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2017 | 789 | 0.030 |
Why?
|
| Freedom | 1 | 2012 | 69 | 0.030 |
Why?
|
| Radiography | 2 | 2001 | 7023 | 0.030 |
Why?
|
| India | 1 | 2018 | 2197 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2022 | 4199 | 0.030 |
Why?
|
| Acute-Phase Reaction | 1 | 1991 | 91 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 1999 | 2539 | 0.030 |
Why?
|
| Mesocricetus | 1 | 1991 | 252 | 0.030 |
Why?
|
| Social Class | 1 | 2000 | 1999 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 1 | 1991 | 438 | 0.020 |
Why?
|
| Certification | 1 | 2014 | 424 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 1758 | 0.020 |
Why?
|
| Family | 1 | 2021 | 3147 | 0.020 |
Why?
|
| Information Management | 1 | 2010 | 101 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2703 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2000 | 5078 | 0.020 |
Why?
|
| Prognosis | 2 | 2021 | 29063 | 0.020 |
Why?
|
| Referral and Consultation | 2 | 2018 | 3528 | 0.020 |
Why?
|
| Sepsis | 1 | 2003 | 2593 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2014 | 725 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2021 | 2987 | 0.020 |
Why?
|
| Genotype | 1 | 2023 | 12951 | 0.020 |
Why?
|
| Curriculum | 1 | 2002 | 3605 | 0.020 |
Why?
|
| Europe | 1 | 2015 | 3339 | 0.020 |
Why?
|
| Patents as Topic | 1 | 2009 | 103 | 0.020 |
Why?
|
| Climate | 1 | 2009 | 147 | 0.020 |
Why?
|
| Population Density | 1 | 2008 | 196 | 0.020 |
Why?
|
| Cricetinae | 1 | 1991 | 2472 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2000 | 5391 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 3617 | 0.020 |
Why?
|
| Neoplasms | 2 | 2016 | 21683 | 0.020 |
Why?
|
| Genome | 1 | 2016 | 1808 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2429 | 0.020 |
Why?
|
| Child Welfare | 1 | 2011 | 523 | 0.020 |
Why?
|
| Otitis Media | 1 | 2009 | 277 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2009 | 348 | 0.020 |
Why?
|
| Cities | 1 | 2009 | 513 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10252 | 0.020 |
Why?
|
| Canada | 1 | 2011 | 2065 | 0.020 |
Why?
|
| Caregivers | 1 | 1998 | 2094 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2010 | 747 | 0.020 |
Why?
|
| Health Literacy | 1 | 2010 | 414 | 0.020 |
Why?
|
| Bacillus anthracis | 1 | 2005 | 123 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2005 | 118 | 0.020 |
Why?
|
| Craniocerebral Trauma | 1 | 2009 | 482 | 0.020 |
Why?
|
| Physicians, Primary Care | 1 | 2011 | 591 | 0.020 |
Why?
|
| Brain | 2 | 2022 | 26385 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2010 | 1147 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2009 | 2297 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1991 | 2216 | 0.010 |
Why?
|
| Probability | 1 | 2009 | 2505 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2023 | 15519 | 0.010 |
Why?
|
| Public Sector | 1 | 2005 | 265 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9438 | 0.010 |
Why?
|
| Automation | 1 | 2005 | 584 | 0.010 |
Why?
|
| Private Sector | 1 | 2005 | 392 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2007 | 792 | 0.010 |
Why?
|
| Arthritis | 3 | 1951 | 659 | 0.010 |
Why?
|
| Phototherapy | 1 | 2004 | 377 | 0.010 |
Why?
|
| Motivation | 1 | 2010 | 1971 | 0.010 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2003 | 347 | 0.010 |
Why?
|
| Diatrizoate Meglumine | 1 | 1999 | 83 | 0.010 |
Why?
|
| Medicaid | 1 | 2013 | 2736 | 0.010 |
Why?
|
| Fibula | 1 | 2001 | 269 | 0.010 |
Why?
|
| Milk, Human | 1 | 2003 | 490 | 0.010 |
Why?
|
| Maternal Health Services | 1 | 2003 | 455 | 0.010 |
Why?
|
| Laparotomy | 1 | 1999 | 473 | 0.010 |
Why?
|
| Cytokines | 1 | 1991 | 7322 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1991 | 13033 | 0.010 |
Why?
|
| Home Care Services | 1 | 2002 | 606 | 0.010 |
Why?
|
| Liver | 1 | 1991 | 7474 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1991 | 12072 | 0.010 |
Why?
|
| Cognition | 1 | 2010 | 6770 | 0.010 |
Why?
|
| Iodine Isotopes | 1 | 1951 | 90 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 29786 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 21746 | 0.010 |
Why?
|
| Salicylates | 1 | 1950 | 126 | 0.010 |
Why?
|
| Pregnancy | 1 | 1991 | 29144 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 2001 | 1947 | 0.010 |
Why?
|
| Iodine | 1 | 1951 | 286 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2004 | 4687 | 0.000 |
Why?
|
| Immunization, Passive | 1 | 1949 | 623 | 0.000 |
Why?
|
| Contrast Media | 1 | 1999 | 5300 | 0.000 |
Why?
|
| Arthritis, Rheumatoid | 2 | 1951 | 3712 | 0.000 |
Why?
|
| Rheumatic Diseases | 1 | 1951 | 592 | 0.000 |
Why?
|
| Diarrhea | 1 | 1951 | 1348 | 0.000 |
Why?
|
| Neuralgia | 1 | 1949 | 570 | 0.000 |
Why?
|
| Estrogens | 1 | 1950 | 1566 | 0.000 |
Why?
|
| Blood Transfusion | 1 | 1949 | 1301 | 0.000 |
Why?
|
| Prostate | 1 | 1950 | 1774 | 0.000 |
Why?
|
| Animals | 1 | 1991 | 168757 | 0.000 |
Why?
|